Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for thioridazine hydrochloride submitted by Mylan Pharmaceuticals Inc. for this generic antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thioridazine hydrochloride (thioridazine hydrochloride)

Snippet

SUPPL AP for THIORIDAZINE HYDROCHLORIDE (THIORIDAZINE HYDROCHLORIDE)